Page last updated: 2024-09-04

atazanavir sulfate and candesartan

atazanavir sulfate has been researched along with candesartan in 2 studies

Compound Research Comparison

Studies
(atazanavir sulfate)
Trials
(atazanavir sulfate)
Recent Studies (post-2010)
(atazanavir sulfate)
Studies
(candesartan)
Trials
(candesartan)
Recent Studies (post-2010) (candesartan)
1,1022465901,929412589

Protein Interaction Comparison

ProteinTaxonomyatazanavir sulfate (IC50)candesartan (IC50)
Epidermal growth factor receptorHomo sapiens (human)3.2769
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)5.9472
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)3.0652
Cytochrome P450 3A4Homo sapiens (human)9
Adenosine receptor A3Homo sapiens (human)1.2199
Cytochrome P450 2C9 Homo sapiens (human)3
Beta-3 adrenergic receptorHomo sapiens (human)4.3
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)1.2199
Alpha-2B adrenergic receptorHomo sapiens (human)3.843
Sodium-dependent noradrenaline transporter Homo sapiens (human)3.0652
Thromboxane-A synthase Homo sapiens (human)3.0594
Type-1 angiotensin II receptorHomo sapiens (human)0.0405
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)1.2199

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ma, C; Wang, J1
Huang, YY; Li, Z; Lin, Y; Liu, R; Luo, HB; Wang, X; Zhan, CG1

Other Studies

2 other study(ies) available for atazanavir sulfate and candesartan

ArticleYear
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8

    Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Pharmaceutical Preparations; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles

2021
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-23, Volume: 118, Issue:8

    Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Protease Inhibitors; Quinolines; Reproducibility of Results; SARS-CoV-2; Sulfides; Tetrazoles

2021